ClinicalResearch.com

Pet wearables like smart collars and health trackers are becoming popular tools to help monitor things like your pet’s activity, behavior, and even heart rate. As one example, veterinarians can use the data to adjust diuretic therapy to the minimum effective dose for pets with heart conditions. These devices can also give owners a better peek into how their furry companions are doing between vet visits, and may even help spot changes early. These gadgets are fun (and super useful), but vets say they’re not a substitute for regular care and preventive visits.

How Pet Health Trackers are Changing Veterinary Clinical Trials and Pet Care Veterinary algorithms build individual baselines to detect subtle shifts in a pet's health and therapy response.

A Nova Scotia woman living with advanced ovarian cancer is helping scientists shape a new research project exploring immune-based treatments. By sharing her experience, she’s helping researchers better understand the disease, and develop therapies that work with the body’s immune system. Her experience is a reminder that patient voice can play a vital role in advancing cancer research.

NS ovarian cancer patient helps inform 'natural killer' treatment project In 2018, Halifax's Teresa Arthur was diagnosed with Stage 4 ovarian cancer. Now eight years into her journey, she is helping a Halifax lab research how to treat ovarian cancer with what's called natural killer cell immunotherapy.

New research suggests that repeated head impacts, even without a concussion, may change the gut microbiome. Scientists looking at the experiences of college football players in the US found that their gut bacteria shifted within days after hard hits, and continued to change over the season. Because the gut plays a role in inflammation and brain health, this study adds to growing interest in the gut–brain connection.

Head impacts are associated with altered gut microbiome in football players Non-concussive head impacts—hits to the head that don't cause clinically detectable symptoms—are correlated with subsequent changes to the gut microbiome in a small sample of US collegiate football players, according to a study published in PLOS One by Ahmet Ay and Kenneth Douglas Belanger of Co...

Recent reporting highlights that psychedelic-assisted therapies (including psilocybin-based treatments) are approaching potential FDA review and approval, following controlled clinical trials for conditions such as PTSD, depression, and substance use disorders. The research emphasizes tightly regulated dosing, structured psychotherapy, and clinical oversight in order to distinguish these treatments from recreational use. Several states, including Texas, are investing in infrastructure and research ahead of possible regulatory changes.

Psychedelic treatments are on the verge of FDA approval. Why Texas is pushing for them | Houston Public Media Texas is helping shape the future of psychedelic therapies. Here's how they work and what access could look like.